Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients
Abstract Background Adrenocortical carcinoma (ACC) is a rare malignant endocrine tumour. Due to a high tumour recurrence rate, the post-operative overall survival (OS) and disease-free survival (DFS) of ACCs is limited. Our research aims to identify the role of the epithelial-mesenchymal transition...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
BMC
2019-11-01
|
| Sraith: | BMC Cancer |
| Ábhair: | |
| Rochtain ar líne: | https://doi.org/10.1186/s12885-019-6389-3 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|